Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers

Conclusion: 68Ga-FAPI PET/CT is a promising imaging probe that has a significant impact on TNM stage and clinical management. 68Ga-FAPI PET/CT promises to be a crucial new technology that will improve on conventional radiologic imaging methods such as contrast-enhanced CT and contrast-enhanced MRI typically acquired for cancer staging.

Source: Journal of Nuclear Medicine - November 2, 2023 Category: Nuclear Medicine Authors: Koerber, S. A., Rohrich, M., Walkenbach, L., Liermann, J., Choyke, P. L., Fink, C., Schroeter, C., Spektor, A.-M., Herfarth, K., Walle, T., Calais, J., Kauczor, H.-U., Jaeger, D., Debus, J., Haberkorn, U., Giesel, F. L. Tags: Clinical Investigations Source Type: research